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In Brief
Mou et al. show that brain-derived
neurotrophic factor (BDNF) rs12291063
minor C allele disrupts binding and
transactivation by the transcriptional
regulator, heterogeneous nuclear
ribonucleoprotein D0B, and it is
associated with lower ventromedial
hypothalamic BDNF expression and
obesity. BDNF augmentation may be
specifically beneficial for treating obesity
in individuals with the CC genotype.
Cell Reports
ReportHuman Obesity Associated with an Intronic SNP
in the Brain-Derived Neurotrophic Factor Locus
Zongyang Mou,1,2 Thomas M. Hyde,3,4,5 Barbara K. Lipska,6 Keri Martinowich,3,4 Peter Wei,1,7 Chiew-Jen Ong,1,7
Lindsay A. Hunter,1,7 Gladys I. Palaguachi,1,7 Eva Morgun,1,2 Rujia Teng,1 Chen Lai,1,7 Tania A. Condarco,2
Andrew P. Demidowich,2 Amanda J. Krause,2 Leslie J. Marshall,8 Karin Haack,9 V. Saroja Voruganti,9,10 Shelley A. Cole,9
Nancy F. Butte,11 Anthony G. Comuzzie,9 Michael A. Nalls,12 Alan B. Zonderman,13 Andrew B. Singleton,12
Michele K. Evans,14 Bronwen Martin,15 Stuart Maudsley,16,17,18 Jack W. Tsao,2,7,19 Joel E. Kleinman,3,4,5
Jack A. Yanovski,2 and Joan C. Han1,2,20,21,*
1Unit on Metabolism and Neuroendocrinology
2Section on Growth and Obesity
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, MD 20892, USA
3The Lieber Institute for Brain Development
4Department of Psychiatry and Behavioral Sciences
5Department of Neurology
Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
6Human Brain Collection Core, National Institute of Mental Health (NIMH), NIH, Bethesda, MD 20892, USA
7Departments of Neurology and Physical Medicine and Rehabilitation, Uniformed Services University of the Health Sciences, Bethesda,
MD 20814, USA
8Preclinical Microbicide & Prevention Research Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA
9Department of Genetics, Texas Biomedical Research Institute and Southwest National Primate Research Center, San Antonio,
TX 78245, USA
10Department of Nutrition and UNC Nutrition Research Institute, University of North Carolina, Chapel Hill, Kannapolis, NC 28081, USA
11USDA/ARS Children’s Nutrition Research Center, Baylor College of Medicine, Houston, TX 77030, USA
12Molecular Genetics Section, National Institute of Aging (NIA), Bethesda, MD 20892, USA
13Behavioral Epidemiology Section
14Health Disparities Research Section
15Metabolism Unit
16Receptor Pharmacology Unit
NIA, Baltimore, MD 21224, USA
17Translational Neurobiology Group, VIB Department of Molecular Genetics
18Laboratory of Neurogenetics, Institute Born-Bunge
University of Antwerp, 2610 Wilrijk, Belgium
19Department of Neurology
20Department of Pediatrics
University of Tennessee Health Science Center, Memphis, TN 38163, USA
21Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis, TN 38103, USA
*Correspondence: jhan14@uthsc.edu
http://dx.doi.org/10.1016/j.celrep.2015.09.065
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARY
Brain-derived neurotrophic factor (BDNF) plays a key
role in energy balance. In population studies, SNPs of
the BDNF locus have been linked to obesity, but the
mechanism by which these variants cause weight
gain is unknown. Here, we examined human hypo-
thalamic BDNF expression in association with 44
BDNF SNPs. We observed that the minor C allele of
rs12291063 is associated with lower human ventro-
medial hypothalamic BDNF expression (p < 0.001)
and greater adiposity in both adult and pediatric co-
horts (p values < 0.05). We further demonstrated that
themajor T allele for rs12291063 possesses a binding
capacity for the transcriptional regulator, heteroge-Cell Repneous nuclear ribonucleoprotein D0B, knockdown
of which disrupts transactivation by the T allele.
Binding and transactivation functions are both dis-
rupted by substituting C for T. These findings provide
a rationale for BDNF augmentation as a targeted
treatment for obesity in individuals who have the
rs12291063 CC genotype.INTRODUCTION
Genetic factors play a role not only in thepredisposition to obesity
(Loos, 2012), but also in the effectiveness of obesity treatments
(Choquet and Meyre, 2011). Genetic variation of the brain-
derived neurotrophic factor (BDNF) locus is an important poten-
tial therapeutic target because BDNF plays a key role in energyorts 13, 1073–1080, November 10, 2015 ª2015 The Authors 1073
Figure 1. Association of BDNF rs12291063
CC Genotype with Lower VMH BDNF
Expression and Higher BMI in a Postmor-
tem Adult Cohort
(A) ANCOVAs compared BDNF expression (tran-
scripts shown in Figure S1) by rs12291063 ge-
notype in 84 subjects (Table S1). Overall p values
for each transcript were as follows: I (p = 0.11),
IIb (p = 0.00097), IIc (p = 0.06), and VIb (p =
0.002). Post hoc LSD pair-wise comparisons
were performed for transcripts with significant
overall p values (IIb and IVb). CC subjects had
lower expressions of transcripts IIb and VIb.
Adjusted means ± 95% confidence intervals of
back-transformed log-expression data (normal-
ized to the geometric mean of ACTB, B2M, and
GUSB) are shown.
(B) BMI (log-transformed to normalize) was
compared by ANOVA (overall p = 0.02), with post
hoc LSD showing no difference in BMI between
CT and TT (p = 0.19), higher BMI in CC versus TT
(p = 0.007), and a trend toward higher BMI in CC
versus CT (p = 0.06). Medians (interquartile
ranges) are shown.
(C) Subjects with the rs12291063 CC genotype
had higher BMI compared to combined TT and CT
subjects (p = 0.03). TT and CT individuals were
grouped together because of similar BDNF
expression and BMI. Adjusted means ± 95%
confidence intervals of back-transformed data are
shown.homeostasis by functioning asadownstream regulator of the lep-
tin-proopiomelanocortin pathway (Xu et al., 2003).Bdnf+/mice
(Lyons et al., 1999) and BDNF+/ humans (Han et al., 2008)
exhibit hyperphagic behavior and obesity. BDNF is abundantly
expressed in the ventromedial hypothalamus (VMH) (Xu et al.,
2003), and selective deletion ofBdnf from theVMHanddorsome-
dial hypothalamus leads to obesity in mice (Unger et al., 2007).
In human studies, associations have been observed between
obesity and SNPs of the BDNF gene locus, most of which are in-
tronic (Gong et al., 2013; Speliotes et al., 2010).
With the emerging evidence that non-coding genetic variants
play an important role in gene regulation (Cooper, 2010), we hy-
pothesized that SNPs within intronic regions of the BDNF locus
could alter hypothalamic BDNF expression and, thereby, influ-
ence energy balance and serve as potential therapeutic targets
for genotype-specific treatment of obesity. We examined the
association of the BDNF locus SNPs with human VMH BDNF
expression and body composition in multiple pediatric and adult
cohorts. We then investigated the mechanistic role of intronic
SNP rs12291063, which emerged as the strongest predictor of
hypothalamic BDNF expression and body mass index (BMI).1074 Cell Reports 13, 1073–1080, November 10, 2015 ª2015 The AuthorsRESULTS
The rs12291063 CC Genotype Is
Associated with Decreased BDNF
Expression in Human VMH
Relative expressions of the five most
abundant BDNF transcripts in humanhypothalamus (I, IIb, IIc, IV, and VIb) (Han et al., 2008) were
measured by quantitative real-time PCR in postmortem human
VMH-region tissue obtained from 84 adults (Table S1).
Subjects were genotyped for 44 SNPs within or near the
BDNF locus (Table S2). Of the 44 SNPs examined, only
rs12291063 was significantly associated with BDNF expres-
sion after correction for multiple comparisons. Minor allele
rs12291063 CC genotype was significantly associated with
lower BDNF transcript IIb and nominally associated with
lower BDNF transcript VIb expressions (Figure 1A). Upstream
of coding exon IX, rs12291063 is located within the intron
between noncoding exons VIII and VIIIh (Figure S1). Addi-
tional BDNF SNPs showing nominal associations with
BDNF expression that were not significant after correction
for multiple comparisons are indicated in Table S2. Because
minor allele frequency (MAF) for rs12291063 is higher in
African-American compared to Non-Hispanic Caucasian sub-
jects, we confirmed the nominal associations of rs12291063
with BDNF transcripts IIb and VIb in the sub-cohort of
54 African-American subjects (p = 0.002 and p = 0.006,
respectively).
Figure 2. Association of BDNF rs12291063
CC Genotype with Higher BMI, BMI-Z,
Percentage of Body Fat, and Fat Mass in
Children
(A and B) The rs12291063 CC genotype was
significantly associated with higher BMI (A) and
higher BMI-Z (B) in a cohort of 837 healthy children
(Table S4).
(C and D) Among 726 subjects who underwent
body composition analysis (451 by dual-energy
X-ray absorptiometry and 275 by air-displacement
plethysmography), the rs12291063 CC genotype
was associated with significantly higher percent-
age of body fat (C) and higher fat mass (D).
ANCOVAs were performed followed by post hoc
pair-wise LSD comparisons when overall p values
were significant (overall p values for BMI, BMI-Z,
percentage of body fat, and fat mass were 0.0002,
0.001, 0.04, and 0.04, respectively; only significant
p values from post hoc pair-wise comparisons are
shown in the figures). Adjusted means ± 95%
confidence intervals of back-transformed BMI,
percentage of body fat, and fat mass data are
shown. Adjusted means ± SEM of BMI-Z data are
shown.The rs12291063 CC Genotype Is Associated with
Greater BMI and Adiposity
Postmortem Adult Cohort
Subjects with the rs12291063 CC genotype had significantly
greater BMI compared to subjects with the TT genotype (p =
0.007; Figure 1B) and a trend toward greater BMI compared to
CT subjects (p = 0.06; Figure 1B). BMI was not significantly
different between CT and TT groups (p = 0.19). After adjustment
for age, sex, and race, the CC genotype remained significantly
associated with higher BMI when compared with combined CT
and TT subjects (p = 0.03; Figure 1C). We also confirmed the as-
sociation of rs12291063 with BMI in the sub-cohort of African-
American subjects (p = 0.04 in one-tailed analysis; data not
shown).
Adult African-American Cohorts
Because the MAF of rs12291063 is higher in African-American
compared to Caucasian cohorts (Sherry et al., 2001), we exam-
ined the association between rs12291063 and obesity in a sam-
ple of 29,151 adult subjects of African-American race who were
enrolled in the Population Architecture using Genomics and
Epidemiology (PAGE) consortia study (Gong et al., 2013). The
rs12291063 MAF for C was 0.30 in this cohort. The number
of C alleles was positively associated with BMI (adjusted for
age, sex, study site, and ancestry principal components; p =
0.00008, b = +0.007; Table S3).
In a sample of 677 adult subjects of African-American race
who were enrolled in the Healthy Aging in Neighborhoods of Di-
versity across the Life Span (HANDLS) study (Evans et al., 2010),Cell Reports 13, 1073–1080, Nors12291063 MAF for C was 0.30. In one-
tailed replication analyses, the number
of C alleles was positively associated
with percentage fat (adjusted for age,
sex, and the first ten component vectorsfrom multidimensional scaling to account for population sub-
structure; p = 0.02, b = +0.01) and fat mass (additionally adjusted
for height2; p = 0.04, b = +0.06), and a trend toward association
was observed for BMI (p = 0.07, b = +0.02).
Healthy Pediatric Cohort
The association between rs12291063 and obesity was further
studied in a cohort of 837 healthy children (age 12.6 ± 3.3
years; 58% female; 53% Non-Hispanic Caucasian, 36% Afri-
can-American; BMI-Z 1.24 ± 1.18) recruited as volunteers
for clinical studies at the NIH (Table S4). The rs12291063
MAF for C was 0.02, 0.34, and 0.17 for Non-Hispanic Cauca-
sian, African-American, and Asian/Hispanic/other subjects,
respectively. Genotype distributions within racial/ethnic sub-
groups were consistent with Hardy-Weinberg equilibrium
(HWE) (p values > 0.05). The rs12291063 CC subjects had
significantly higher BMI and higher BMI-Z than CT and TT sub-
jects (p values < 0.01; Figures 2A and 2B). BMI also was higher
in the CT subjects compared to the TT subjects (p = 0.049), but
BMI-Z was not significantly different (p = 0.13). We also
confirmed the association of rs12291063 with BMI-Z in the
sub-cohort of African-American children (p = 0.04 in one-tailed
analysis; data not shown). Among 726 children who underwent
body composition analysis, subjects with the rs12291063 CC
genotype had a significantly greater percentage of body fat
and fat mass compared to the CT and TT subjects (p values <
0.05; Figures 2C and 2D). CT and TT subjects had similar
adjusted percentage of body fat (p = 0.84) and similar adjusted
fat mass (p = 0.96).vember 10, 2015 ª2015 The Authors 1075
Figure 3. Nuclear Extract Proteins between 30 and 40 kDa Size with
Greater Binding to the Major T Allele of rs12291063
(Lane 1) No-oligonucleotide control showing nonspecific binding of nuclear
proteins to the beads. (Lanes 2 and 3) Black bracket shows bands between 30
and 40 kDa in size that appear higher in intensity for the T allele (lane 2) probe
compared to the C allele (lane 3) probe. Table S5 shows the isolated proteins
identified by mass spectrometry. (Lane 4) YY1 protein was selected as an
ubiquitous transcription factor to serve as an additional molecular weight
standard (68 kDa). (Lane 5) Molecular weight standard is shown.Replication in a Pediatric Hispanic Cohort
In a sample of 813 pediatric subjects of Hispanic ethnicity who
were enrolled in the Viva La Familia Study (Butte et al., 2006) at
Baylor College of Medicine, the rs12291063 MAF for C was
0.33. In one-tailed replication analyses, the number of minor C
alleles was positively associated with BMI (adjusted for age
and sex; p = 0.04, b = +0.09), a trend toward association was
observed for BMI-Z (p = 0.08, b = +0.07) and fat mass (addition-
ally adjusted for height2; p = 0.09, b = +0.07), and no significant
association was observed for percentage of body fat (p = 0.19).
Transcriptional Enhancer hnRNPD0B Binds
Preferentially to Major T Allele Sequence at rs12291063
Locus
To examine the mechanism through which rs12291063 might
alter BDNF expression and lead to obesity, we used Genomatix
SNPInspector software to predict potential transcription factor
binding at the rs12291063 locus, and we found that its major
T allele sequence matches the AAATACC motif of the Mt site,
located upstream of the human DES gene. Mt binds to an
unidentified nuclear extract protein, designated as Mt-binding
factor, that is required for full transcriptional activity of DES
(Gao et al., 1998).
We hypothesized that the T allele for SNP rs12291063 is a
binding site for a transcriptional regulatory protein and that pres-
ence of the C allele decreases binding of this protein. We per-1076 Cell Reports 13, 1073–1080, November 10, 2015 ª2015 The Auformed a streptavidin-agarose bead pull-down procedure
(Deng et al., 2003) to isolate HeLa nuclear proteins that bind pref-
erentially to the T allele sequence of rs12291063. We observed
that protein bands between 30 and 40 kDa in size were more
intense for the T allele compared to the minor C allele (Figure 3).
Sequencing by mass spectrometry of nuclear proteins that
bound to the major T allele of rs1229063 identified a total
of 23 proteins (Table S5). From this list, we selected heteroge-
neous nuclear ribonucleoprotein (hnRNP)D0B (NP_002129.2;
AAB96683.1) as the most likely candidate protein because of
its molecular weight (32 kDa), relative abundance (11.3%),
high binding affinity to DNA in a sequence-specific manner,
and known role as a transcriptional enhancer (Tolnay et al.,
1999, 2000).
To confirm that hnRNPD0B binds to the rs12291063 locus, we
conducted electrophoretic mobility shift assay (EMSA) experi-
ments. We observed that an HeLa nuclear protein bound prefer-
entially to the T allele sequence versus the C allele sequence of
rs12291063, with 50% lower binding intensity for the minor allele
sequence (p < 0.0001; Figures 4A and 4B). Competition assays
with unlabeled T allele probe showed significantly diminished in-
tensity of the labeled major T probe-protein band (p values <
0.006; Figures 4A and 4B), but no diminution from unlabeled C
allele probe (p values > 0.11; Figures 4A and 4B), confirming
that the observed DNA-protein band for the T allele probe is
sequence specific and that the nuclear protein has a higher affin-
ity for the T allele over the C allele.
We proceeded to perform supershift experiments using a
mousemonoclonal pan-anti human hnRNP antibody (Figure 4C).
The primary DNA-protein bandwas diminished by the addition of
a pan-hnRNP antibody and a supershifted complex formed. In
contrast, mouse IgG did not alter the primary DNA-protein
band, which confirmed the specificity of the observed supershift.
A similar pattern was observed for both the T and C allele se-
quences of rs12291063, but the band intensities were lower for
the C allele, consistent with its decreased binding capability for
an hnRNP.
We then performed EMSA supershift experiments using puri-
fied recombinant hnRNPD0B protein (Figure 4D). We observed
that hnRNPD0B bound to both the T and C allele sequences,
but with lower intensity for the C allele sequence. These DNA-
protein complexes were supershifted by the addition of a
pan-hnRNP antibody, but the supershifted band intensities still
remained consistently lower for the C allele. The addition of
mouse IgG induced supershifted bands of comparatively lower
molecular weight to form, but the original DNA-protein com-
plexes were still present, suggesting that IgG nonspecifically
binds to a site on the biotin-labeled oligonucleotides distinct
from the DNA site that binds hnRNPD0B.
Minor C Allele of rs12291063 Decreases Luciferase
Reporter Gene Expression
Because hnRNPD0B has been shown to enhance transcription
in vitro (Tolnay et al., 2000), we hypothesized that substitution
of T with C at rs12291063 leads to decreased binding of
hnRNPD0B, resulting in decreased gene expression. We cloned
the T or C allele and the identical 250-bp flanking sequence
of rs12291063 into pGL3-SV40 luciferase reporter vectorsthors
Figure 4. Preferential Binding of Transcriptional Enhancer HnRNPD0B to the Major T Allele of rs12291063
(A and B) EMSAs were performed using HeLa nuclear extract and biotin-labeled oligos containing the major and minor alleles of rs12291063. The major T oligo
bound to nuclear protein to form a band (lane 1, black arrow) that was twice as intense (p < 0.0001; B) as the minor C oligo-protein band (A, lane 2). Competition
assays with 100–4003 unlabeled T-oligo showed significantly diminished intensity of the labeled T oligo-protein band (A, lanes 4–6; p values < 0.006; B), but not
with unlabeled C-oligo even at 4003 excess (A, lanes 7–10; p values > 0.11; B). Mean ± SEM is shown for three experiments, for which (A) is a representative gel
(*p < 0.01 for post hoc LSD after ANOVA).
(C) In EMSA supershift experiments (n = 3, representative gel in C), the oligo-protein band (C, lane 1, black arrow) was diminished by the addition of pan-hnRNP
antibody and a supershifted complex formed (C, lane 2, white arrow). Normal mouse IgG did not alter the oligo-protein band (C, lane 3). A similar pattern was
observed for the C-oligo (C, lanes 4–6), but with lower band intensities.
(D) In EMSAs using hnRNPD0B (n = 3, representative gel in D), binding was observed for the T (D, lane 1) and C (D, lane 4) oligos, and the DNA-protein complexes
were supershifted by the addition of pan-hnRNP (D, lanes 2 and 5), but the band intensities were lower for the C oligo. The addition of IgG (Dd, lanes 3 and 6)
generated supershifted bands of comparatively lower molecular weight, but the original DNA-protein bands remained.(Figure 5A) in HEK293 cells. The construct containing the C
allele exhibited 46% lower luciferase activity compared to the
construct containing the T allele (p = 0.003; Figure 5B).
Transactivation Function of the Major T Allele of
rs12291063 Is Disrupted by Reduction of hnRNPD
Protein Expression
We performed small interfering RNA (siRNA)-mediated knock-
down of hnRNPD0B to confirm that the observed decrease
in expression was due to diminished hnRNPD0B binding at the
C allele. siHNRNPD significantly decreased hnRNPD protein
expression (p < 0.01) in both T and C allele construct-containing
cells (Figure 5C). The siHNRNPD treatment was associated with
22% lower luciferase expression induced by the major T allele
compared to siControl (p < 0.01; Figure 5D). However, there
was no significant difference in luciferase expression betweenCell RepsiHNRNPD and siControl in cells containing the minor C allele
(p = 0.2; Figure 5D), thus supporting a specific transactivation
activity induced by binding of hnRNPD0B with the major T allele
of rs12291063. Furthermore, cells co-transfected with the minor
C allele and siControl showed a significant decrease in luciferase
activity compared to cells co-transfected with the major T allele
and siControl (p = 0.000005; Figure 5D), which serves as sec-
ondary confirmation that the minor C allele causes decreased
gene expression.
DISCUSSION
We observed that the rs12291063 CC genotype was associated
with lower expressions of BDNF transcripts IIb and VIb in human
VMHand higher BMI and adiposity inmultiple racially diverse pe-
diatric and adult cohorts. Our in vivo and clinical findings indicateorts 13, 1073–1080, November 10, 2015 ª2015 The Authors 1077
Figure 5. Decreased rs12291063 Minor C
Allele Luciferase Reporter Gene Expression
and Disruption of Transactivation Function
of the Major T Allele by Reduction in
HnRNPD Protein Expression
(A) The 250-bp sequences containing either
the T allele or the C allele of rs12291063 were
each cloned into a pGL3 luciferase reporter
vector driven by an SV40 promoter at the Hindlll
site.
(B) HEK293 cells transiently transfected with the
minor C allele construct exhibited 46% lower
Firefly luciferase activity (normalized to co-trans-
fected Renilla luciferase) compared to cells
transfected with the major T allele construct (n =
12 replicates; p = 0.003).
(C) Cells were transiently transfected with either
the T or C allele rs12291063 construct along with
HNRNPD siRNA (siHNRNPD) or Control siRNA
(siControl), and they were subjected to western
blot to detect the protein expression level
of hnRNPD (normalized to GAPDH). Cells con-
taining the T allele construct and siHNRNPD ex-
hibited an average of 33% lower hnRNPD protein
expression compared to matched cells with
siControl (n = 4; p = 0.0008). Cells containing the
C allele construct and siHNRNPD exhibited an
average of 29% lower hnRNPD protein expression compared to matched cells with siControls (n = 4; p = 0.009).
(D) Parallel transfections from (C) were carried out to assess luciferase activity. Cells with the T allele construct and siHNRNPD exhibited 22% lower Firefly
luciferase expression compared to the T allele construct with siControl (n = 8; p = 0.000002). Cells containing the C allele construct with siHNRNPD exhibited
comparable luciferase expression compared to the C allele construct with siControl (n = 8; p = 0.2). Cells with the T allele construct and siControl exhibited 22%
lower Firefly luciferase expression compared to cells with the C allele construct and siControl (n = 8; p = 0.000005). Two-tailed, independent sample t tests were
performed and means ± SEMs are shown.that BDNF rs12291063, which had an MAF of 30% within our
Hispanic and African-American cohorts, could play an important
role in the pathogenesis of obesity in these populations.
Mechanistically, our data suggest that diminished binding of
hnRNPD0B at the rs12291063 locus in individuals with the CC
genotype could cause decreased BDNF mRNA expression
and protein concentrations within the hypothalamus, potentially
leading to excessive energy intake and weight gain.
Regulation of BDNF expression is complex, with multiple pro-
moters responding to a variety of control mechanisms, giving
rise to distinctly regulated mRNA variants with different brain re-
gion expression patterns (Pruunsild et al., 2007; Zheng et al.,
2012). BDNF transcripts IIb and VIb comprise 38% of the total
BDNF mRNA expression in the hypothalamus (Han et al.,
2008). Thus, decreased expression of these two transcripts
could have significant impact on body weight regulation.
Our findings provide a clinically relevant potential mechanism
for the obesity risk associated with a common noncoding variant
of BDNF. Genetic association studies have identified many ge-
netic variants associated with obesity, but their clinical utility
for obesity treatment is currently limited (Loos, 2012). Elucidation
of the functional consequences of these genetic variants are
needed to advance personalized remedies targeting specific
deficits on an individual basis (El-Sayed Moustafa and Froguel,
2013). With this goal in mind, our observations could serve as
the basis for developing therapies aimed at potentiating hypo-
thalamic BDNF signaling as a specific treatment for obesity in in-
dividuals who have the rs12291063 CC genotype.1078 Cell Reports 13, 1073–1080, November 10, 2015 ª2015 The AuEXPERIMENTAL PROCEDURES
Please see the Supplemental Experimental Procedures for additional details.
Human Brain Sample Subjects
Brain tissue was obtained from the Offices of the Chief Medical Examiner of
Washington, DC, and of Northern Virginia (Clinical Brain Disorders Branch,
IRP, NIMH collection) at autopsy from non-neurologic non-psychiatric control
subjects who suffered sudden deaths. All the tissues were donated with
informed consent from the next of kin. Further details on cohort selection have
been reported previously (Lipska et al., 2006). The region of VMHwas dissected
from frozen brain specimens using anatomic landmarks. The qPCR and SNP
genotyping were performed (see the Supplemental Experimental Procedures).
Human Subjects
The following four cohorts were investigated: (1) adults of African-American
race from the PAGE consortia (Gong et al., 2013; Table S3); (2) adults of Afri-
can-American race from the HANDLS study (Evans et al., 2010); (3) pediatric
volunteers participating in clinical studies conducted at the NIH; and (4) chil-
dren and adolescents of Hispanic heritage from the Viva La Familia longitudinal
study (Butte et al., 2006). Informed consent and assent were obtained from
adult subjects and parents/guardians of minors. All methods for obtaining
clinical data from the subjects were approved by the respective Institutional
Review Board at each site.
Bioinformatics
SNPInspector software (Genomatix Software) was used to identify candidate
transcription factors at the SNP loci.
Protein Isolation and Identification
A streptavidin-agarose bead pull-down procedure, as previously described
(Deng et al., 2003), was used to isolate nuclear proteins that bind at thethors
rs12291063 locus. Excised gel bands were submitted to Protech for protein
isolation and sequencing by mass spectrometry.
EMSAs
The 50-biotinylated and unlabeled 25-bp oligonucleotides containing themajor
and minor allele sequences at the rs12291063 locus were obtained from Invi-
trogen. Recombinant hnRNPD0B protein expressed in E.coli was obtained
from OriGene Technologies. EMSAs with competition and supershift assays
were performed using LightShift Chemiluminescent EMSA kit (Pierce Protein
Biology Products) and results were digitized and quantified as previously
described (Schneider et al., 2012).
Luciferase Reporter and siRNA Knockdown Assays
The 250-bp sequences containing either the major or the minor allele of
rs12291063 were cloned into pGL3 luciferase reporter vector driven by an
SV40 promoter (Promega) at the Hindlll site between the promoter and the
firefly Luc gene. HEK293 cells were cultured and transiently transfected with
the constructs using FuGENE HD Transfection Reagent (Promega). For lucif-
erase activity assay with hnRNPD depletion, HEK293 cells were transiently
co-transfected with HNRNP siRNA or Control siRNA (SignalSilence, Cell
Signaling Technology). Dual Luciferase Reporter Assay System (Promega)
was used to quantify firefly luciferase activity. Efficiency of siRNA knockdown
for hnRNPD was verified by western blot using pan-hnRNP antibody and
GAPDH antibody (Santa Cruz Biotechnology).
Statistical Analyses
SPSS Statistics Version 17.0 software (IBM) was used for statistical analyses.
Univariate analyses of covariance (ANCOVAs) with post hoc pair-wise least
significant difference (LSD) comparisons were performed to assess the asso-
ciation of genotype with BDNF expression, BMI, BMI-Z, body fat percentage,
and fat mass. EMSA band intensities from three separate experiments were
compared using ANOVA with post hoc LSD. Firefly luciferase activity and
hnRNP protein expression were compared using two-tailed, independent
sample t tests.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
one figure, and five tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.09.065.
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